Home › Teva Agrees to Buy NuPathe for $144 Million, Outbidding Endo
 

Keywords :   


Teva Agrees to Buy NuPathe for $144 Million, Outbidding Endo

2014-01-21 19:16:48| Biotech - Topix.net

Teva Pharmaceutical Industries Ltd. agreed to buy NuPathe Inc. for $144 million, outbidding Endo Health Solutions Inc. to gain NuPathe's migraine patch.

Tags: buy million agrees endo

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
05.11Shoppers warned over luxury advent calendar scams
05.11Durable Floor Coating from HMG Paints Transforms FC United\'s SMRE Bar
05.11Teknos Poland Honored by Farby i Lakiery
05.11Xumo teams up with Target to offer Hisense Xumo TVs
05.11KT launches 8K AI-powered IPTV set-top box
05.11Tropical Storm Rafael Graphics
More »